http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014140739-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 |
filingDate | 2013-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2014140739-A |
titleOfInvention | IMIDAZO [1, 2-B] Pyridazine Compounds, Compositions of Such Compounds and Methods of Their Use |
abstract | 1. The compound of the formula: or a pharmaceutically acceptable salt thereof, wherein: A is a cyclic C-hydrocarbyl or a 4-7 membered heterocycle; D is a 4-7 membered heterocycle; each R independently is —OR, —N (R), - C (O) R, —C (O) OR, —C (O) N (R), —N (R) C (O) OR, cyano, halogen or optionally substituted C-hydrocarbyl or 2-12 membered heterocarbyl, where optional substitution means optional substitution with one or more R substituents; each R independently represents —OR, —N (R), —C (O) R, —C (O) OR, —C (O) N (R), —N (R) C (O) OR, cyano or halogen; each R is independently is hydrogen or an optionally substituted C-hydrocarbyl or 2-12 membered heterocarbyl, where optional substitution means optional substitution with one or more substituents selected from cyano, halogen or hydroxyl; each R is independently —OR, —N (R), —C ( O) R, -C (O) OR, -C (O) N (R), -N (R) C (O) OR, cyano, halogen or optionally substituted C-hydrocarbyl or 2-12 membered heterocarbyl, where optional substitution means optional substitution with one or more substituents selected from amino, cyano, halogen, hydr xylitol or R; each independently represents hydrogen or optionally substituted Cgidrokarbil or 2-12 membered heterocarbyl, where optional substitution is optionally substituted with one or more substituents selected from amino, cyano, hydroxyl or halogen; n has a value of 1-3; and m has a value of 0-3; under conditions that: 1) R is different from hydroxyl or optionally substituted phenyl or pyridinyl; 2) when D is diazapine and A is pyridinyl, R is different from —C (O) O-tert-butyl; 3) when D is piperazine, A is phenyl and R is chlorine, R is |
priorityDate | 2012-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.